As the global population ages and demand for vision aids increases, the 'Argus II' is showing great results for offering comprehensive vision assistance. Trialled recently at the Manchester Royal Eye Hospital on patient Ray Flynn, the 'Argus II' was able to restore partial sight for the senior.
The 'Argus II' works by placing an implant into the patient's retina; the accompanying headset then transfers video from the built-in camera to the implant, which relays it to the brain. The device offers patients the ability to regain sight after loss from degenerative ailments.
The success of the 'Argus II' vision aid has doctors at the Manchester Royal Eye Hospital eager to continue trialling the technology to allow patients to regain some of their sight.
Vision-Repairing Implants
The 'Argus II' is a Vision Aid that Sends Video to the Wearer's Brain
Trend Themes
1. Vision-restoring Implants - Innovations in vision implants allow for the restoration of sight, presenting new opportunities for patient treatment.
2. Neuroprosthetics - Advancements in neuroprosthetic technology are revolutionizing the field of medical devices and improving the quality of life for patients.
3. Sensory Augmentation - Emerging technologies for sensory augmentation, like the 'Argus II', have the potential to transform the way patients with disabilities experience the world.
Industry Implications
1. Medical Devices - The development of innovative, implantable medical devices for vision restoration represents a significant opportunity for growth and expansion within the industry.
2. Ophthalmology - The 'Argus II' and other vision-restoring implants are set to transform the field of ophthalmology, offering new treatment options for patients with degenerative eye conditions.
3. Biotechnology - Recent advancements in vision-restoring implants demonstrate the transformative power of biotechnology for addressing medical challenges and improving quality of life for patients.